Skinaisp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Suspended
Registry date
2021-05-07
Share capital
14 000,00 PLN
Activity description

Skinai is developing artificial intelligence software for the early detection of skin cancer. Dermatologists and oncologists are involved in its research and testing as the team works toward a tool for physicians.

Registered address
pl. Jana Kilińskiego 2, 35-005 Rzeszów, Poland
Website
skinai.plWebsite active

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 11.91kMedianUSD 72.17kAverageUSD 3.11m
Net profit
This companyUSD -3.96kMedianUSD 69.14AverageUSD 80.67k
Operating costs
This companyUSD 15.88kMedianUSD 75.48kAverageUSD 2.93m
Assets
This companyUSD 22.74kMedianUSD 121.09kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2021-05-20. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
Aid for SME access to finance — aid for start-ups
–

Tenders

No recorded participation in tenders.

Authorized Representatives

Aneta Niedziela – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board is independently authorised to make declarations on behalf of the company. In the case of a multi-member management board, the joint action of two members of the management board or of a member of the management board with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Aneta Niedziela (62)
126$1,701.7845%
Filip Stanisław Noworolnik (31)
84$1,134.5230%
70$945.4325%

Beneficial owners

Person

Competitors

Name
CannamedaiS.A.
NanovelosS.A.
Medaisp. z o.o.
Scanomesp. z o.o.
InventroS.A.
4cell TherapiesS.A.
Liver Aisp. z o.o.
Oncotherics PolandS.A.
Diamaticsp. z o.o.
IncellvuS.A.

Change history

DateEvent
2026-01-12Business suspended
2021-05-07Entered in the register

FAQ

Last updated: 2026-08-28